GDF11 is Involved in Human Hepatic Carcinoma Cells SMMC-7721 Proliferation and Sensitivity to DDP
-
摘要:目的
研究GDF11(growth differentiation factor 11)过表达对肝细胞癌SMMC-7721细胞体外增殖能力及顺铂敏感度的影响。
方法前期成功构建GDF11过表达的SMMC-7721细胞,同时以空载体感染细胞组及野生型细胞组为对照。CCK-8法检测细胞增殖能力,平板克隆形成实验检测细胞克隆形成能力。CCK-8法检测GDF11过表达对细胞顺铂药物敏感度的影响。
结果Western blot结果验证,已成功构建GDF11过表达的SMMC-7721细胞。GDF11过表达可明显抑制SMMC-7721细胞的体外增殖能力,在96、120及144 h时抑制作用最显著(P<0.05),且实验组细胞较对照组克隆形成能力明显减弱(P<0.05)。GDF11过表达能够增强肝细胞癌SMMC-7721细胞对顺铂的敏感度,顺铂浓度取20 μg/ml及40 μg/ml时,与对照组相比差异有统计学意义(P<0.05)。
结论肝细胞癌SMMC-7721细胞过表达GDF11蛋白后,其体外增殖及克隆形成能力明显降低,对化疗药物顺铂的敏感度增强。
Abstract:ObjectiveTo explore the influence of growth differentiation factor 11 (GDF11) overexpression on hepatic carcinoma cells SMMC-7721 proliferation ability and sensitivity to DDP in vitro.
MethodsPrevious study had successfully built SMMC-7721 cells with GDF11 over-expression. Meanwhile, empty vector infected cells and wild-type cells were treated as controls. Cells proliferation ability was examined by CCK-8 assay, and the proliferation curve was calculated. Colony formation assay was adopted to evaluate colony formation ability. The SMMC-7721 cells were treated with various concentrations of DDP, then the cell viability was measured using CCK-8 assay.
ResultsWestern blot showed SMMC-7721 cells with GDF11 over-expression had successfully built. The overexpression of GDF11 could significantly inhibit the proliferation of SMMC-7721 cells in vitro, and the effect were significant at 96, 120, 144h (P<0.05) . Meanwhile GDF11 over-expression group had lower ability of colony formation than control groups(P<0.05) . The over-expression of GDF11 made SMMC-7721 cells more sensitive to DDP, and the effect were significant at 20 and 40μg/ml DDP (P<0.05) .
ConclusionThe over-expression GDF11 could inhibit the proliferation and colony formation abilities of SMMC-7721 cells, and enhance its sensitivity to DDP.
-
Key words:
- Hepatic carcinoma /
- GDF11 /
- Proliferation /
- DDP /
- Sensitivity
-
-
-
[1] EI-serag HB, Rudolph KL. Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7): 25 57-76. [1] EI-serag HB, Rudolph KL. Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7) : 2557-76.
[2] Ng KK, Lo CM, Liu CL, et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplantt[J]. Arch Surg, 2008, 143(1) : 68-74.
[2] Ng KK, Lo CM, Liu CL, et al. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplantt[J]. Arch Surg, 2008, 143(1): 68-74. [3] Kim do Y, Paik YH, Ahn SH, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection[J]. Oncology, 2007, 72 Suppl 1: 52-7.
[3] Kim do Y, Paik YH, Ahn SH, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection[J]. Oncology, 2007, 72 Suppl 1: 52-7. [4] McPherron AC. Metabolic Functions of Myostatin and Gdf11[J]. Immunol Endocr Metab Agents Med Chem, 2010, 10(4) : 217-31.
[4] McPherron AC. Metabolic Functions of Myostatin and Gdf11[J]. Immunol Endocr Metab Agents Med Chem, 2010, 10(4): 217-31. [5] Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184): 649-52. [5] Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184) : 649-52.
[6] Shi Y, Liu JP. Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord[J]. J Neurosci, 2011, 31 (3): 883-93. [6] Shi Y, Liu JP. Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord[J]. J Neurosci, 2011, 31(3) : 883-93.
[7] Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014, 344(6184) : 630-4.
[7] Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014, 344(6184): 630-4. [8] Zhang Y, Shao J, Yang T, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPAR gamma[J]. Gene, 2015, 557(2): 209-14. [8] Zhang Y, Shao J, Yang T, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPAR gamma[J]. Gene, 2015, 557(2) : 209-14.
[9] Zarzynska JM. Two faces of TGF-beta1 in breast cancer[J]. Mediators Inflamm, 2014, 2014: 141747.
[9] Zarzynska JM. Two faces of TGF-beta1 in breast cancer[J]. Mediators Inflamm, 2014, 2014: 141747. [10] Heldin CH, Landström M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelialmesenchymal transition[J]. Curr Opin Cell Biol, 2009, 21(2) : 166-76.
[10] Heldin CH, Landström M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelialmesenchymal transition[J]. Curr Opin Cell Biol, 2009, 21(2): 166-76. [11] Moses H, Barcellos-Hoff MH. TGF-β biology in mammary development and breast cancer[J]. Cold Spring Harb Perspect Biol, 2011, 3(1) : a003277.
[11] Moses H, Barcellos-Hoff MH. TGF-β biology in mammary development and breast cancer[J]. Cold Spring Harb Perspect Biol, 2011, 3(1): a003277. [12] Massagué J. TGF-β in cancer[J]. Cell, 2008, 134(2) : 215-30.
[12] Massagué J. TGF-β in cancer[J]. Cell, 2008, 134(2): 215-30. [13] Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor[J]. J Surg Res, 2015, 198(1): 50-6. [13] Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor[J]. J Surg Res, 2015, 198(1) : 50-6.